| Immunogen Inc (IMGN) | |||
|---|---|---|---|
| 5.39 -0.06 (-1.1%) | 08-08 16:00 | ||
| Open: | 5.51 | Pre. Close: | 5.45 |
| High: | 5.53 | Low: | 5.18 |
| Volume: | 2,033,333 | Market Cap: | 1,190M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 5.534 - 5.562 | 5.562 - 5.58 |
| Low: | 5.116 - 5.152 | 5.152 - 5.174 |
| Close: | 5.337 - 5.393 | 5.393 - 5.428 |
| Stock Technical Analysis | |
|---|---|
| Overall: |  |
| Target: | Six months: 6.47 One year: 7.56 |
| Support: | Support1: 4.84 Support2: 4.40 |
| Resistance: | Resistance1: 5.54 Resistance2: 6.47 |
| Pivot: | 5.08  |
| Moving Averages: | MA(5): 5.18 MA(20): 5.13 MA(100): 4.56 MA(250): 5.38 |
| MACD: | MACD(12,26): 0.15 Signal(12,26,9): 0.15  |
| %K %D: | %K(14,3): 90.31 %D(3): 73.57 |
| RSI: | RSI(14): 58.96 |
| 52-Week: | High: 7.77 Low: 3.1 Change(%): 3.7 |
| Average Vol(K): | 3-Month: 3551 10-Days: 2919 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ IMGN ] has closed below upper band by 21.8%. Bollinger Bands are 20.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: NASDAQ Global Select | |
| Sector: Healthcare | |
| Industry: Biotechnology | |
| Shares Out. (M) | 220.71 |
| Shares Float (M) | 171.68 |
| % Held by Insiders | 0.40 |
| % Held by Institutions | 95.25 |
| Shares Short (K) | 14860 |
| Shares Short Prior Month (K) | 16020 |
| Stock Financials | |
|---|---|
| EPS | -0.590 |
| Book Value (p.s.) | 1.130 |
| Profit Margin | -179.64 |
| Operating Margin | -170.72 |
| Return on Assets (ttm) | -26.4 |
| Return on Equity (ttm) | -101.0 |
| Qtrly Rev. Growth | -16.4 |
| Gross Profit (p.s.) | -0.368 |
| Sales Per Share | 0.405 |
| EBITDA (p.s.) | -0.683 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | -186.31 |
| Levered Free Cash Flow (M) | -97.83 |
| Stock Valuation | |
|---|---|
| PE Ratio | -9.14 |
| PEG Ratio | |
| Price to Book value | 4.77 |
| Price to Sales | 13.30 |
| Price to Cash Flow | -6.39 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
